We are live on ! Find out more
Geneva Advisors

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.81B
AUM Growth
+$209M
Cap. Flow
-$89.8M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.73%
Holding
880
New
85
Increased
289
Reduced
288
Closed
113
Avg Time Held
2.1 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$39.4M
2
SSNC icon
SS&C Technologies
SSNC
+$35.4M
3
XRAY icon
Dentsply Sirona
XRAY
+$34.3M
4
SCHW icon
Charles Schwab
SCHW
+$16.5M
5
ADI icon
Analog Devices
ADI
+$14.6M

Top Sells

Rank Stock Value
1
TSCO icon
Tractor Supply
TSCO
+$51.9M
2
BURL icon
Burlington
BURL
+$42.3M
3
CELG
Celgene
CELG
+$38.2M
4
TMUS icon
T-Mobile US
TMUS
+$30.8M
5
MANH icon
Manhattan Associates
MANH
+$25.7M

Sector Composition

Rank Sector Weight
1 Financials 17.33%
2 Healthcare 16.31%
3 Technology 15.88%
4 Consumer Discretionary 12.37%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EQNR icon
201
Equinor
EQNR
$93B
$2.08M 0.04%
126,078
+11,528
+10% +$198K
2014 Q2
12 quarters
AMTX icon
202
Aemetis
AMTX
$59.2M
$2.08M 0.04%
1,562,431
+50,800
+3% +$67.6K
2014 Q2
12 quarters
AM icon
203
DELISTED
Antero Midstream Partners
AM
$2.07M 0.04%
62,463
-2,830
-4% -$94.3K
2016 Q3
3 quarters
FDX icon
204
FedEx
FDX
$71.2B
$2.07M 0.04%
9,521
+60
+0.6% +$11.8K
2013 Q2
16 quarters
SYK icon
205
Stryker
SYK
$118B
$2.07M 0.04%
14,895
-30
-0.2% -$4.12K
2013 Q2
16 quarters
TWO.PRA
206
DELISTED
Two Harbors Investment Corp 8.125% Series A Preferred Stock
TWO.PRA
$2.06M 0.04%
74,300
+5,800
+8% +$156K
2017 Q1
1 quarter
SRCLP icon
207
DELISTED
Stericycle
SRCLP
$2.04M 0.04%
30,540
-220
-0.7% -$15.5K
2016 Q2
4 quarters
IVW icon
208
iShares S&P 500 Growth ETF
IVW
$65.4B
$2.03M 0.03%
59,284
-46,952
-44% -$1.59M
2015 Q4
6 quarters
MRCC icon
209
DELISTED
Monroe Capital Corp
MRCC
$2.01M 0.03%
131,687
+18,200
+16% +$283K
2015 Q4
6 quarters
MFA icon
210
MFA Financial
MFA
$584M
$1.96M 0.03%
58,433
+9,597
+20% +$318K
2016 Q3
3 quarters
BMRN icon
211
BioMarin Pharmaceuticals
BMRN
$11.7B
$1.95M 0.03%
21,507
+35
+0.2% +$3.18K
2013 Q2
16 quarters
HAWK icon
212
DELISTED
Blackhawk Network Holdings
HAWK
$1.95M 0.03%
44,795
+1,078
+2% +$45K
2016 Q2
4 quarters
GIS icon
213
General Mills
GIS
$19.1B
$1.95M 0.03%
35,207
-4,125
-10% -$235K
2013 Q2
16 quarters
LGND icon
214
Ligand Pharmaceuticals
LGND
$5.74B
$1.95M 0.03%
25,691
+673
+3% +$47.1K
2016 Q1
5 quarters
FULLL
215
DELISTED
Great Elm Capital Corp 8.25% Notes due 2020
FULLL
$1.92M 0.03%
75,700
+1,530
+2% +$39.2K
2013 Q2
16 quarters
NVS icon
216
Novartis
NVS
$284B
$1.91M 0.03%
25,532
-688
-3% -$48.8K
2013 Q2
16 quarters
KMB icon
217
Kimberly-Clark
KMB
$65.3B
$1.9M 0.03%
14,749
+64
+0.4% +$8.33K
2013 Q2
16 quarters
NGHCP
218
DELISTED
National General Holdings Series A Preferred Stock
NGHCP
$1.9M 0.03%
72,975
+5,100
+8% +$131K
2014 Q2
12 quarters
STWD icon
219
Starwood Property Trust
STWD
$3.94B
$1.89M 0.03%
84,409
+12,605
+18% +$282K
2016 Q1
5 quarters
BXMT icon
220
Blackstone Mortgage Trust
BXMT
$1.7B
$1.88M 0.03%
59,450
+9,385
+19% +$292K
2017 Q1
1 quarter
ARCC icon
221
Ares Capital
ARCC
$13.3B
$1.88M 0.03%
114,666
+18,626
+19% +$314K
2014 Q1
13 quarters
MDT icon
222
Medtronic
MDT
$128B
$1.87M 0.03%
21,059
+201
+1% +$16.9K
2013 Q2
16 quarters
WMT icon
223
Walmart
WMT
$1.02T
$1.86M 0.03%
73,875
+2,163
+3% +$54.9K
2013 Q2
16 quarters
GBDC icon
224
Golub Capital BDC
GBDC
$3.17B
$1.85M 0.03%
+98,783
New +$1.93M
2017 Q2
0 quarters
BBDC icon
225
Barings BDC
BBDC
$866M
$1.84M 0.03%
104,555
+55,389
+113% +$1.01M
2017 Q1
1 quarter

Similar funds

Geneva Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Geneva Advisors held 880 positions worth $5.81B, up 3.7% from $5.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Geneva Advisors's Q2 2017 filing shows 85 new, 289 increased, 288 reduced and 113 closed positions. Its largest new stake was Golub Capital BDC: 98,783 shares worth $1.85M. The largest sale was Tractor Supply, an estimated $51.9M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Geneva Advisors's largest Q2 2017 buy was Golub Capital BDC: 98,783 shares worth $1.85M.
  • Geneva Advisors added most to CME Group in Q2 2017, an estimated $39.4M increase.
  • Geneva Advisors's biggest Q2 2017 reduction was Tractor Supply, cutting an estimated $51.9M.
  • Geneva Advisors fully exited Syneos Health in Q2 2017, selling an estimated $11.3M.
  • Geneva Advisors's ten largest holdings make up 26% of its $5.81B portfolio in Q2 2017.
  • Geneva Advisors opened 85 new positions and closed 113 in Q2 2017.
  • Geneva Advisors's portfolio value rose 3.7% quarter-over-quarter to $5.81B.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.